IGC Pharma Newsroom

"Legislative Committee In Ireland Calls For Marijuana Legalization And Decriminalization Of 'All Illicit Drugs'" - Marijuana Moment

BenzingaOct 22 15:26 ET

IGC Pharma Announces Patient Enrollment at Toronto's Baycrest in Phase 2 Trial Investigating IGC-AD1

AccesswireOct 17 08:30 ET

IGC Pharma Wins 2 Awards in Phase 1 of NIA's AI PREPARE Challenge, Advancing Alzheimer's Early Prediction Research

PR LogOct 1 12:22 ET

Express News | Lawmakers Urge DEA To Finalize Marijuana Rescheduling Proposal

BenzingaOct 1 11:44 ET

Express News | Shares of Cannabis Stocks Are Trading Higher Following a Report Suggesting That Vice President Harris Wants to Legalize Marijuana

BenzingaSep 30 11:16 ET

12 Health Care Stocks Moving In Friday's After-Market Session

BenzingaSep 27 16:31 ET

Express News | IGC Pharma From4 Filing Shows Company Director James P Moran Bought 588,235 Shares Of Common Stock At A Price Of $0.34/Share

BenzingaSep 27 16:14 ET

Express News | "National Agriculture Regulators Group Grapples With Intoxicating Hemp For The First Time; FDA's Norm Birenbaum Says Existing FDA Regulatory Frameworks 'Do Not Apply To Large Segments Of The Market, Like Inhalable Products, Where We Have Tremendous...

BenzingaSep 26 13:22 ET

Express News | IGC Pharma Inc: Initiation of Disease-Modifying Investigational Trials, Expected in Early 2025

ReutersSep 4 08:02 ET

IGC Pharma Advances IGC-AD1 Toward Clinical Trials as a Potential Anti-Amyloid Plaque Treatment for Alzheimer's Disease

BusinesswireSep 4 08:00 ET

Novo, Amgen, Other Pharma Stocks Have Clinical Trials That Could Send Them Soaring -- Barrons.com

Dow JonesSep 3 00:00 ET

Express News | IGC Pharma Inc : Ascendiant Capital Markets Raises Target Price to $3.75 From $3.5

ReutersSep 2 02:41 ET

IGC Announces Results of Its 2024 Annual Stockholders Meeting

BusinesswireAug 26 19:00 ET

Express News | IGC Pharma Announces Research Demonstrating New Molecule IGC-1C Targets Tau Protein in Alzheimer's Disease

ReutersAug 22 09:00 ET

Express News | IGC Pharma Says IGC-1A Has Been Identified As A Potential GLP-1 Agonist

BenzingaAug 20 08:06 ET

Express News | IGC Pharma: Expands Drug Portfolio to Metabolic Disorders With IGC-1a, Potential New GLP-1 Agonist

ReutersAug 20 08:05 ET

IGC Pharma Revenue Declines 51% YoY Due To Completion Of Its Legacy Project In India, Highlights Important Milestones In Alzheimer's Research

BenzingaAug 9 09:24 ET

India Globalization Capital GAAP EPS of -$0.03 In-line, Revenue of $0.27M Misses by $0.04M

Seeking AlphaAug 9 03:33 ET

IGC Pharma Q1 2025 GAAP EPS $(0.03), Inline, Sales $272.000K Miss $310.000K Estimate

BenzingaAug 9 01:48 ET

IGC Pharma 1Q Loss/Shr 3c >IGC

Dow JonesAug 8 21:30 ET